Humacyte (HUMA) PT Raised to $7.50 at TD Cowen
Tweet Send to a Friend
TD Cowen analyst Joshua Jennings raised the price target on Humacyte (NASDAQ: HUMA) to $7.50 (from $6.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
